Medical devices as drug delivery platforms: nanotechnology aids and translational issues
Targeting 2.0. Towards a rational design to selective nanocarriers in oncology
Epigenetic biomarkers in cancer: moving towards liquid biopsy
Carbohydrate-based vaccine development
Molecular determinants of gastric cancer: predisposing factors and intra-tumoral heterogeneity
Study of the contribution of clusters of CTCs to the metastasis of breast cancer
On the statistical evaluation of diagnostic and prognostic tests: When patient information beyond test’s result can make a difference